MedTrace Logo

Social Media Navigation Aid Kits for Urinary Incontinence

NCT05858125 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-01-16

No results posted yet for this study

Summary

This study aims to compare the effectiveness of a Urogynecology Social Media Navigation Aid Kit (SNAK) and routine counseling in the treatment of women with newly diagnosed urinary incontinence. The study will conduct a randomized controlled trial on treatment-naïve patients seeking care for urinary incontinence. The research will have five aims:

1. evaluate the impact of SNAK on patients' self-efficacy in managing urinary incontinence symptoms
2. compare patient satisfaction with urinary incontinence treatment between SNAK and routine counseling groups
3. assess the impact of SNAK on urinary incontinence severity
4. evaluate the impact of SNAK on patients' quality of life
5. examine if there is an impact of SNAK on patients' treatment decision.

Participants will be randomized to routine counseling alone versus routine counseling plus a SNAK. They will be given a baseline survey at their initial enrollment to the study. The investigators will follow up at a 3-month interval where they will be given a post-intervention survey.

Conditions

Interventions

OTHER

Social Media Navigation Aid Kit

The Social media Navigation Aid Kit (SNAK) was created by using search terms, "urinary incontinence", "urinary leakage", and "urogynecology", and querying various websites/blogs, Facebook, Instagram, and YouTube. These social media platforms were chosen based on the top three social media platforms used in Americans aged 50 to \>65 years old according to Pew Research Analytics (Pew paper). The experienced reviewer evaluated each platform for users that provided relevant, accurate, and specific content. The department of Urogynecology at UNM independently reviewed the curated pages and users for approval. Once approved, the various users and pages were then collected and a flyer was created. The flyer will be available via hardcopy, email, or text per patient preference.

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Tasha Serna-Gallegos, MD · University of New Mexico

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-24
Primary Completion
2024-12-17
Completion
2024-12-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05858125 on ClinicalTrials.gov